Venous Thromboembolism: all 708 studies

Page 3 of 8. Open to participants first (152), then studies with results posted, then the rest; newest registration first within each.

• Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) StudyCompletedNCT02303431Phase 1Results posted
• Educating Nurses About Venous Thromboembolism (VTE) PreventionCompletedNCT02301793Not applicableResults posted
• Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS)CompletedNCT02297373Results posted
• EINSTEIN Junior: Oral Rivaroxaban in Children With Venous ThrombosisCompletedNCT02234843Phase 3Results posted
• Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of AgeCompletedNCT02223260Phase 2Results posted
• ODEN Trial: Option vs. Denali IVC FiltersTerminatedNCT02201277Not applicableResults posted
• Safety of Dabigatran Etexilate in Blood Clot Prevention in ChildrenCompletedNCT02197416Phase 3Results posted
• The Angel® Catheter Pivotal Clinical TrialCompletedNCT02186223Not applicableResults posted
• Cancer Venous Thromboembolism (VTE)CompletedNCT02073682Phase 3Results posted
• Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin ThromboprophylaxisCompletedNCT02070237Phase 1Results posted
• Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)CompletedNCT02064439Phase 3Results posted
• Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical ProceduresCompletedNCT02037607Results posted
• Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal SurgeryCompletedNCT01976988Phase 3Results posted
• Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)CompletedNCT01895777Phase 3Results posted
• Toronto Thromboprophylaxis Patient Safety InitiativeCompletedNCT01869075Not applicableResults posted
• Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower LimbsCompletedNCT01857583Phase 3Results posted
• Angel® Catheter Early Feasibility Clinical StudyTerminatedNCT01847196Not applicableResults posted
• Improving Anticoagulation Control in VISN 1CompletedNCT01653405Not applicableResults posted
• Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee ArthroscopyCompletedNCT01629381Phase 2Results posted
• Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)CompletedNCT01583218Phase 3Results posted
• PREvention of VENous Thromboembolism In Hemorrhagic Stroke PatientsTerminatedNCT01573169Phase 3Results posted
• Fondaparinux in Critically Ill Patients With Renal FailureCompletedNCT01467583Phase 4Results posted
• Safety Study of the Angel™ Catheter in Subjects With Risk of Pulmonary EmbolismCompletedNCT01403090Phase 1Results posted
• Compression Treatment Effects on Complications and Healing of Achilles Tendon RuptureCompletedNCT01317160Not applicableResults posted
• Study Of Lybrel In Relation To Venous ThromboembolismCompletedNCT01297348Results posted
• PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial PilotCompletedNCT01274637Phase 3Results posted
• BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement SurgeryCompletedNCT01225822Phase 2Results posted
• A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip ArthroplastyCompletedNCT01203098Phase 2Results posted
• A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee ArthroplastyCompletedNCT01203072Phase 2Results posted
• Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran EtexilateCompletedNCT01184989Phase 4Results posted
• A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip ArthroplastyCompletedNCT01181167Phase 3Results posted
• Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture SurgeryCompletedNCT01181141Phase 3Results posted
• A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee ArthroplastyCompletedNCT01181102Phase 3Results posted
• Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement SurgeryTerminatedNCT01153698Results posted
• Sickle Cell Trait and the Risk of Venous ThromboembolismTerminatedNCT01148940Results posted
• Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXACompletedNCT01139658Results posted
• Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of AgeCompletedNCT01083732Phase 2Results posted
• The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following TraumaCompletedNCT01050153Not applicableResults posted
• An Observational Study On The Safety And Tolerability Of Prolonged Thrombosis Prophylaxis With Fragmin®CompletedNCT01046903Results posted
• Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)CompletedNCT01014403Phase 1Results posted
• Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous ThromboembolismCompletedNCT01004939Results posted
• Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).CompletedNCT00986154Phase 3Results posted
• Remote Home Prothrombin Time (PT)/International Normalized Ratio (INR) Monitoring and Patient Management SystemCompletedNCT00978445Not applicableResults posted
• Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer PatientsCompletedNCT00966277Phase 4Results posted
• Fragmin for the Treatment of Acute VTE in Pediatric Cancer PatientsCompletedNCT00952380Phase 2Results posted
• Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy.CompletedNCT00878826Phase 2/3Results posted
• A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer PatientsTerminatedNCT00876915Phase 3Results posted
• Safety and Tolerability of Dabigatran Etexilate in AdolescentsCompletedNCT00844415Phase 2Results posted
• Prothrombin Times Outside the Therapeutic Range in Otherwise Stable PatientsCompletedNCT00814177Phase 2Results posted
• Aspirin Prophylaxis for Venous Thromboembolism in GlioblastomaTerminatedNCT00790452Phase 2Results posted
• Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed ThrombolysisCompletedNCT00790335Phase 3Results posted
• A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical ProphylaxisTerminatedNCT00789399Not applicableResults posted
• Once Weekly Subcutaneous Ports for the Administration of AnticoagulantsCompletedNCT00774748Not applicableResults posted
• Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)CompletedNCT00680186Phase 3Results posted
• Long-term Active Surveillance Study for Oral Contraceptives (LASS)CompletedNCT00676065Results posted
• Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip ArthroplastyCompletedNCT00657150Phase 3Results posted
• Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)CompletedNCT00634907Not applicableResults posted
• Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill PatientsCompletedNCT00571649Phase 3Results posted
• Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTECompletedNCT00558259Phase 3Results posted
• The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma PatientsCompletedNCT00531843Phase 2/3Results posted
• Use of Oral Contraceptives (OCs) Containing Dienogest and Risk of Venous ThromboembolismCompletedNCT00523614Results posted
• Celect Vena Cava Filter Clinical TrialCompletedNCT00470626Not applicableResults posted
• Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical PatientsTerminatedNCT00445328Phase 4Results posted
• Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension StudyCompletedNCT00439725Phase 3Results posted
• D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous ThromboembolismTerminatedNCT00428441Not applicableResults posted
• Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous ThromboembolismTerminatedNCT00423683Phase 3Results posted
• Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement.CompletedNCT00362232Phase 3Results posted
• Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous ThromboembolismCompletedNCT00291330Phase 3Results posted
• A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.CompletedNCT00246025Phase 2Results posted
• Odiparcil For The Prevention Of Venous ThromboembolismCompletedNCT00244725Phase 2Results posted
• Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement SurgeryCompletedNCT00168818Phase 3Results posted
• Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee ReplacementCompletedNCT00152971Phase 3Results posted
• Bleeding Risk With Apixaban Versus Rivaroxaban in Acute Pulmonary EmbolismCompletedNCT07774273Not applicable
• High-Risk Factors for VTE DeathCompletedNCT07767279
• The Effect of a VTE Prevention Care Bundle in Total Hip Arthroplasty PatientsActive, not recruitingNCT07702903Not applicable
• Timing of Thromboprophylaxis After Postpartum HemorrhageCompletedNCT07689136
• People's Hospital of Xinjiang Uygur Autonomous RegionCompletedNCT07612865Not applicable
• Development and Validation of an Interpretable Machine Learning Model for Predicting Venous Thromboembolism（VTE）in Intensive Care Unit (ICU) PatientsCompletedNCT07596264
• Pressure Ulcer Development Device RelatedCompletedNCT07586748
• Effectiveness and Cost-effectiveness of VTE Prevention Strategies in Gynecological SurgeryActive, not recruitingNCT07455253
• Incidence of Venous Thromboembolism in Patients With Pelvic and Acetabular Fractures (PAF)CompletedNCT07165587
• Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to EnoxaparinCompletedNCT07124819Phase 3
• Incidence of Venous Thromboembolism and Cardiovascular Events in Breast Cancer Patients Undergoing Cyclin-dependent Kinase 4/6 Inhibitors: The Breast Cancer Associated Vascular Events During Cyclin-dependent Kinase 4/6 Inhibitors Therapy (BRAVE-Cyclin) StudyActive, not recruitingNCT07008508
• Recurrence of Thromboembolic Venous Disease of Atypical Location (RUSE)Active, not recruitingNCT06815874
• Venous Thromboembolism During COVID-19 Pandemic: Evaluation of the Association With the Vaccine and COVID-19 InfectionCompletedNCT06806800
• An Observational Study in the United States to Learn How Venous Thromboembolism, Disseminated Intravascular Coagulation, and Sepsis Are RelatedActive, not recruitingNCT06765681
• Thromboembolic Complications in Mild Covid-19 CasesCompletedNCT06695377
• Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized TrialStatus unknownNCT06662253Phase 2/3
• Efficacy of Aspirin in Preventing Venous ThromboembolismCompletedNCT06635317Phase 4
• Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint ReplacementActive, not recruitingNCT06627933
• The Affect Of An Anti-Embolism Stocking ProtocolCompletedNCT06616376Not applicable
• The Safety and Effectiveness of Warfarin Vs Apixaban in Patients with NVAF/ VTE and ESKD on DialysisCompletedNCT06606275
• Evaluating the Risk of Postoperative Venous Thromboembolism in Cervical Cancer PatientsCompletedNCT06556953
• The Protrieve PROTECTOR StudyCompletedNCT06495996Not applicable
• Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer SurgeryActive, not recruitingNCT06451003Not applicable
• Determination of Venous Thromboembolism Risk and Nursing Practices in Patients Hospitalized in Medical ServicesCompletedNCT06445283
• Xueshuantong Injection (Lyophilized) in the Prevention of Venous Thromboembolism (VTE) in Hospitalized PatientsActive, not recruitingNCT06443905
• Risk Factors of Venous Thromboembolism After Colorectal Cancer SurgeryCompletedNCT06302179
• A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC)CompletedNCT06299111Phase 2
• An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous ThromboembolismCompletedNCT06278051

← Venous Thromboembolism overview